POSTS

Post by StevenGrossman | March 14, 2013

Funding Cutbacks at FDA: A Sequester Primer

Post by StevenGrossman | February 12, 2013

The State of the FDA—February 2013

Post by StevenGrossman | November 1, 2012

FDA After the Election—Part 1: Budget

Post by StevenGrossman | September 11, 2012

Why Orphan Drugs are a Key Part of Pharma’s Future

Post by StevenGrossman | August 7, 2012

FDA and the 2012 U.S. Presidential Election

Post by StevenGrossman | July 31, 2012

FDA’s E-Mail Scandal: First Impressions